Daubert Hearings for Zantac Cancer Lawsuits To Be Held in September 2022
A federal judge has scheduled hearings over Zantac cancer lawsuit Daubert motions for September.
A federal judge has scheduled hearings over Zantac cancer lawsuit Daubert motions for September.
Two former district judges have been appointed as valsartan settlement special masters to help bring about a resolution to the litigation.
Valsartan and similar hypertension drugs may carry an increased risk of cancer with long-term use, according to the findings of a new study.
A federal judge is calling on parties in Zantac cancer litigation to finalize a registry of potential plaintiffs and their information as the lawsuits enter the latter stages of pretrial…
Plaintiffs have identified five types of cancer which will be pursued in federal Zantac lawsuits, including bladder cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer.
Dozens of batches of generic metformin are being recalled due to the presence of NDMA; a cancer-causing chemical byproduct which has led to numerous drug recalls in recent years.
A Special Master involved in valsartan litigation has determined Zhejiang Huahei Pharmacticals, the manufacturer of the active ingredient, should pay sanctions for failing to provide appropriate answers to some questions…
Parties involved in litigation over the cancer risks of the heartburn drug Zantac will take part in a Zantac Science Day today and tomorrow in federal court.
A class action lawsuit claims the presence of potentially cancer-causing chemicals made Chantix an illegal and unadulterated drug which was never approved by the FDA.
A pool of 200 randomly selected Zantac cancer claims will form the initial discovery pool, from which the first bellwether cases will be selected.